MAM
Complaints filed against 21 companies and individuals on objectionable and misleading ads
NEW DELHI: A police complaint has been filed in the Gomti Nagar police station in Lucknow against various companies and people with regard to advertisements on sex-power, obesity.
This FIR has been registered on the complaint by Lucknow based IPS officer Amitabh Thakur and social activist Dr Nutan Thakur, who had earlier approached the Lucknow bench of the Allahabad High Court on this issue but were asked by the Court to first approach the police.
Based on their complaint under sections 3/5/7/9/9A Drugs and Magic Remedies (Objectionable Advertisement) Act 1954 has been registered. The accused include a total of 21 companies and individuals like Sri Sai Safed Daag, Capsule More Power, Sex Grow Power, Titanic K 2 Capsule, Yoko Pharmacy, Dr P K Jain Clinic, Dr A K Jain Clinic, Jolly Bawasir, Altaz Dawakhana, Paras Medico, Hashmi Dawakhana, D Fit Capsule, Sanyasi Clinic. Parashuram Ojha is the investigating officer of the case.
The Thakurs had in their public interest litigation appealed that as per section 3 of this Act, no advertisement about increasing sexual pleasure, women menstrual disorder and 54 diseases including diabetes, blindness, deafness, insanity, leucoderma, and obesity can be published while as per section 5, all kinds of magic remedies like talisman, kavach, and tantra is completely prohibited. Section 7 makes their violation a cognizable offence punishable between six months to one year. Justice Uma Nath Singh and Justice Dr Satish Chandra ordered them to avail alternative remedy of registering FIR.
The Bench had said that since the alternative remedy of registering FIR against accused newspapers and companies is available, they should first avail this remedy and they can approach the High Court if they fail to get suitable remedy at that level.
The petitioners had wanted the Information and Broadcasting Ministry, Registrar of Newspapers in India, and the Directorate of Advertising and Visual Publicity to be directed to ensure that such illegal advertisements do not get published in any newspaper or aired TV and all administrative and legal measures should be taken in case of violation.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
